The use of an exopolysaccharide fraction produced by Lactobacillus rhamnosus

摘要

A use is revealed for a fraction containing an exopolysaccharide isolated from bacteria of the species Lactobacillus rhamnosus, preferentially, the Lactobacillus rhamnosus strain KL37C deposited in the PCM under the accession number B/00022, in the production of a drug for the prophylaxis and treatment of autoimmune diseases.